ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) Files An 8-K Entry into a Material Definitive Agreement

ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) Files An 8-K Entry into a Material Definitive Agreement
Item 9.01 Entry Into a Material Definitive Agreement

Story continues below

On March 26, 2018, Eternity Healthcare Inc. (the “Company”) entered into a Credit Loan Agreement with Shenzhen Dongyang Medical Technology Co., Ltd., as lender, and the Company’s wholly-owned subsidiary, Guizhou Tongren Healthy China Biotechnology Co., Ltd., as borrower (“Tongren Healthy”), to which the Company agreed to guaranty payment of the indebtedness under a loan facility providing Tongren Healthy with advances for up to $25 million. Advances under the loan facility bear interest at the rate of 10% per annum. The loan facility has a term of five years. A copy of the Credit Loan Agreement is annexed as Exhibit 10.1 to this report.

Tongren Healthy, the leading stem cell therapy service company serving Guizhou Province and Western China, is constructing a 50,000 square-feet facility for stem cell harvesting, storage and transformation, and patient treatment which is expected to be operational in May 2018. Advances under the credit facility will be used to construct and equip the medical facility and to provide Tongren Healthy with working capital to operate the medical facility.

Item 9.01 Regulation FD Disclosure

On March 29, 2018, the Company issued a press release announcing that it had completed the acquisition of Guizhou Tongren Healthy China Biotechnology Co., Ltd., and that it had entered into the Credit Loan Agreement. A copy of the press release is filed as Exhibit 99.1 to this report.

The information in this Item 9.01 and Exhibit 99.1 shall not be deemed as “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such Section, nor shall it be deemed incorporated by reference in any filing by us under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

EX-10.1 2 f8k032618ex10-1_eternity.htm CREDIT LOAN AGREEMENT Exhibit 10.1   CREDIT LOAN AGREEMENT   授信借款协议    THIS CREDIT LOAN AGREEMENT (hereinafter,…
To view the full exhibit click here


Eternity Healthcare Inc. is a medical device company. The Company is engaged in the discovery, development and marketing of medical devices. The Company is focused on marketing of its needle-free injection device technology. It also includes an over the counter pain treatment device using laser as treatment source. Its products include Nozzles/syringes, Adapters, Nozzle/Adapter Combination Pack and Adapters (Large). The Company’s products are sold to healthcare professionals for use in physicians’ offices, pharmacies and to all consumers. It provides delivery technologies for insulin, human chorionic gonadotropin (hCG), human growth hormone (hGH), Vitamin B12, vaccines, anesthetics, migraine medication and steroids. The Company provides a soft injection system that avoids the use of needles for the delivery of various sorts of injectable medications, including cancer medication. It is a universal injection system that can deliver medication in both pediatrics and adults.

An ad to help with our costs